This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2Muscular Dystrophy
- 1Antisense Oligonucleotide
- 1Cardiac Imaging
- 1Cardiac Intervention
- 1Duchenne Muscular Dystrophy
- 1Dysferlinopathy
-
Fall 2018
The muscular dystrophies are a heterogeneous group of over 30 genetic diseases which are characterized by progressive weakening and deterioration of muscle tissue and which vary with respect to age of onset, pattern of muscle involvement, and severity. To date, no effective therapeutic options...
-
Fall 2022
Background Muscular dystrophy (MD) is a group of inherited neuromuscular disorders with heart disease as a leading cause of morbidity and mortality. Dystrophinopathies such as Duchenne and Becker MD, limb-girdle MD, type 1 myotonic dystrophy (DM1), and facioscapulohumeral MD are most associated...